ATE232106T1 - Regulierung von essgewohnheiten - Google Patents

Regulierung von essgewohnheiten

Info

Publication number
ATE232106T1
ATE232106T1 AT96918064T AT96918064T ATE232106T1 AT E232106 T1 ATE232106 T1 AT E232106T1 AT 96918064 T AT96918064 T AT 96918064T AT 96918064 T AT96918064 T AT 96918064T AT E232106 T1 ATE232106 T1 AT E232106T1
Authority
AT
Austria
Prior art keywords
regulation
eating habits
eating
habits
anlogs
Prior art date
Application number
AT96918064T
Other languages
English (en)
Inventor
Eleftheria Maratos-Flier
Original Assignee
Joslin Diabetes Ct
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=23877870&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ATE232106(T1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Joslin Diabetes Ct filed Critical Joslin Diabetes Ct
Application granted granted Critical
Publication of ATE232106T1 publication Critical patent/ATE232106T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575—Hormones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2217/00—Genetically modified animals
    • A01K2217/05—Animals comprising random inserted nucleic acids (transgenic)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Endocrinology (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Diabetes (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Toxicology (AREA)
  • Engineering & Computer Science (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Child & Adolescent Psychology (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Confectionery (AREA)
  • Diaphragms For Electromechanical Transducers (AREA)
  • Catching Or Destruction (AREA)
  • Table Devices Or Equipment (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
AT96918064T 1995-06-06 1996-06-05 Regulierung von essgewohnheiten ATE232106T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US08/473,022 US5849708A (en) 1995-06-06 1995-06-06 Promotion of eating behavior
PCT/US1996/008798 WO1996039162A1 (en) 1995-06-06 1996-06-05 Regulation of eating behavior

Publications (1)

Publication Number Publication Date
ATE232106T1 true ATE232106T1 (de) 2003-02-15

Family

ID=23877870

Family Applications (1)

Application Number Title Priority Date Filing Date
AT96918064T ATE232106T1 (de) 1995-06-06 1996-06-05 Regulierung von essgewohnheiten

Country Status (8)

Country Link
US (2) US5849708A (de)
EP (1) EP0871463B2 (de)
JP (1) JPH11507517A (de)
AT (1) ATE232106T1 (de)
AU (1) AU721624B2 (de)
CA (1) CA2223153A1 (de)
DE (1) DE69626132T3 (de)
WO (1) WO1996039162A1 (de)

Families Citing this family (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6001968A (en) 1994-08-17 1999-12-14 The Rockefeller University OB polypeptides, modified forms and compositions
US6861053B1 (en) * 1999-08-11 2005-03-01 Cedars-Sinai Medical Center Methods of diagnosing or treating irritable bowel syndrome and other disorders caused by small intestinal bacterial overgrowth
US7048906B2 (en) 1995-05-17 2006-05-23 Cedars-Sinai Medical Center Methods of diagnosing and treating small intestinal bacterial overgrowth (SIBO) and SIBO-related conditions
US6558708B1 (en) * 1995-05-17 2003-05-06 Cedars-Sinai Medical Center Methods for manipulating upper gastrointestinal transit, blood flow, and satiety, and for treating visceral hyperalgesia
US6214790B1 (en) 1998-04-10 2001-04-10 Mayo Foundation For Medical Education And Research Neo-tryptophan
US6716810B1 (en) * 1998-12-09 2004-04-06 Eleanor Roosevelt Institute Composition and method for regulation of body weight and associated conditions
US6603058B1 (en) 1998-12-09 2003-08-05 Oklahoma Medical Research Foundation Non-human animal model for obesity and uses thereof
WO2000040725A1 (en) * 1998-12-28 2000-07-13 Takeda Chemical Industries, Ltd. Screening method
US6221613B1 (en) 1998-12-31 2001-04-24 Synaptic Pharmaceutical Corporation DNA encoding a human melanin concentrating hormone receptor (MCH1) and uses thereof
US6890726B1 (en) 1999-04-06 2005-05-10 Oklahoma Medical Research Foundation Method for selecting recombinase variants with altered specificity
AU5260500A (en) * 1999-05-19 2000-12-05 Astrazeneca Ab Assays for agonists, agonists and inverse agonists of melanin concentrating hormone (mch) binding to the somatostatin-like receptor (slc-1)
CA2383147A1 (en) * 1999-09-20 2001-03-29 Takeda Chemical Industries, Ltd. Mch antagonists
EP1218336A2 (de) * 1999-09-20 2002-07-03 Takeda Chemical Industries, Ltd. Antagonisten des melanin-konzentrierenden hormons
JP2003522184A (ja) * 2000-02-03 2003-07-22 メルク エンド カムパニー インコーポレーテッド メラニン濃縮ホルモン類似体
US7220720B2 (en) * 2000-02-03 2007-05-22 Merk & Co., Inc. Melanin-concentrating hormone analogs
US6429190B1 (en) 2000-12-15 2002-08-06 Pacifichealth Laboratories, Inc. Method for extending the satiety of food by adding a nutritional composition designed to stimulate cholecystokinin(CCK)
US6809104B2 (en) * 2001-05-04 2004-10-26 Tularik Inc. Fused heterocyclic compounds
US20070135425A1 (en) * 2001-05-04 2007-06-14 Amgen Inc. Fused heterocyclic compounds
US7314861B2 (en) * 2001-05-31 2008-01-01 Merck & Co., Inc. Melanin-concentrating hormone analogs
EP1416951A1 (de) * 2001-08-08 2004-05-12 Merck & Co., Inc. Mch (melanin-concentrating hormone) -antagonisten
CA2473229A1 (en) * 2002-01-09 2003-07-24 Merck & Co., Inc. Selective melanin-concentrating hormone type -1 receptor agonists
NZ540328A (en) * 2002-11-06 2008-02-29 Amgen Inc Fused heterocyclic compounds
US7671025B2 (en) 2006-02-24 2010-03-02 Sarentis Therapeutics, Inc. Neurotensin receptor agonists and opioid receptor agonists
US20080220104A1 (en) * 2007-03-08 2008-09-11 Cappello John V Compositions for producing satiety
WO2009033724A1 (en) * 2007-09-11 2009-03-19 Mondobiotech Laboratories Ag Use of c-type natriuretic peptide, alone or incombination with neuropeptide af, as a therapeutic agent
JP4593639B2 (ja) * 2008-03-04 2010-12-08 株式会社マルハニチロ食品 ペプチド含有摂食調節剤
EP3019487A1 (de) 2013-07-09 2016-05-18 Takeda Pharmaceutical Company Limited Heterocyclische verbindung
WO2015073878A1 (en) 2013-11-15 2015-05-21 Ur Diet, Llc Real-time satiety biofeedback
WO2017103224A1 (en) * 2015-12-16 2017-06-22 Institut National De La Sante Et De La Recherche Medicale (Inserm) Method of treatment of amyotrophic lateral sclerosis

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5210076A (en) * 1988-09-13 1993-05-11 Berliner David L Methods of treating Parkinson's disease using melanin
US5049655A (en) * 1989-03-22 1991-09-17 The Salk Institute For Biological Studies Melanin-concentrating hormones
CA2040264A1 (en) * 1990-04-12 1991-10-13 Tatsuhiko Kanmera Parathyroid hormone antagonists

Also Published As

Publication number Publication date
DE69626132T3 (de) 2008-06-05
AU6041896A (en) 1996-12-24
WO1996039162A1 (en) 1996-12-12
DE69626132T2 (de) 2003-12-04
US5849708A (en) 1998-12-15
DE69626132D1 (de) 2003-03-13
EP0871463A4 (de) 1999-09-08
EP0871463B2 (de) 2007-11-21
EP0871463B1 (de) 2003-02-05
CA2223153A1 (en) 1996-12-12
EP0871463A1 (de) 1998-10-21
US20040242487A1 (en) 2004-12-02
JPH11507517A (ja) 1999-07-06
AU721624B2 (en) 2000-07-13

Similar Documents

Publication Publication Date Title
ATE232106T1 (de) Regulierung von essgewohnheiten
ES2124668B1 (es) "nuevosl-arilpirazoles con propiedades plaguicidas.
FR2696338B1 (fr) Ligament artificiel et son mode de presentation.
DE69623472D1 (de) Derivate von dolastatin, dreen herstellung un verwendung
DK0644724T3 (da) Spiseklar cerealie med reduceret fedtindhold
DE69621146T2 (de) Verwendung von Galactanase in Tierfutter
TR199800575T1 (en) Kemokin �-8'in k�sa formlar�.
LV11378A (lv) Veja elektroiekartas kontroles panemiens un ierice
KR960028190U (ko) 사무용 의자
DE59105421D1 (de) Mikrobiologische Oxidation von Ethylgruppen in Heterocyclen.
FI894552A (fi) Anordning i gasregulator.
KR900700481A (ko) 1,4-치환된-2,3.5,6-테트라하이드로 [1,3,6]트리아조시노[1,2,-a] 벤즈이미다졸 및 이의 중간체
DE69621809D1 (de) Mit metallocen stabilisiertes alumoxan
ES1021004Y (es) Hombrera estable y confortable.
DE29516423U1 (de) Kombinations - Schlaf-, Sitz- und Liegemöbel
AU128055S (en) Singlet
KR950005466U (ko) 의자가 부착된 배낭
AU103662S (en) Trousers
KR970016038U (ko) 의자의 등받이를 다양하게 조절하는 의자
KR970006303U (ko) 부시겸 스냅링
ITGE940035V0 (it) Sedile aspirante per water e gruppo deodorante con riciclo dell'aria nell'ambiente.
NO903634L (no) Stillbar sitte- og liggestol.
BR9503702A (pt) Bloco com encaixe e desmontável
KR970008878U (ko) 재털이가 구비된 아암레스트
KR970008440U (ko) 원단공급기에 있어 로울러 상.하 이송구

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties